• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION SYNVISC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION SYNVISC Back to Search Results
Device Problem Unexpected Therapeutic Results (1631)
Patient Problem Pain (1994)
Event Date 08/08/2018
Event Type  Injury  
Event Description
Spoke to (b)(6), a clinical coord from dr (b)(6)'s office.They state the pt is saying that the original synvisc inject back in (b)(6) was ineffective.They are experiencing knee pain in both knees.Inj 8mg/ml (3x2ml), from (b)(6) 2018 to (b)(6) 2018.Is the product compounded? no; is the product over-the-counter? no.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC
Type of Device
SYNVISC
Manufacturer (Section D)
GENZYME CORPORATION
MDR Report Key7780291
MDR Text Key117192505
Report NumberMW5079102
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 08/08/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/13/2018
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Age60 YR
-
-